Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-284.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -268.46% |
| Q3 2025 | 267.88% |
| Q2 2025 | 47.07% |
| Q1 2025 | 15.08% |
| Q4 2024 | -54.48% |
| Q3 2024 | 51.62% |
| Q2 2024 | 6.31% |
| Q1 2024 | -84.66% |
| Q4 2023 | 5.03% |
| Q3 2023 | -13.11% |
| Q2 2023 | 10.37% |
| Q1 2023 | -43.66% |
| Q4 2022 | 0.94% |
| Q3 2022 | -2.85% |
| Q2 2022 | -15.01% |
| Q1 2022 | -3.74% |
| Q4 2021 | -5.61% |
| Q3 2021 | 2.72% |
| Q2 2021 | -7.84% |
| Q1 2021 | 20.90% |
| Q4 2020 | -14.85% |
| Q3 2020 | -97.21% |
| Q2 2020 | 21.27% |
| Q1 2020 | -148.23% |
| Q4 2019 | -9.66% |
| Q3 2019 | 1.88% |
| Q2 2019 | -77.01% |
| Q1 2019 | -3.92% |
| Q4 2018 | -19.46% |
| Q3 2018 | 2.03% |
| Q2 2018 | 38.00% |
| Q1 2018 | -48.54% |
| Q4 2017 | -17.55% |
| Q3 2017 | 36.31% |
| Q2 2017 | -106.02% |
| Q1 2017 | 28.56% |
| Q4 2016 | -175.94% |
| Q3 2016 | 198.37% |
| Q2 2016 | 42.12% |
| Q1 2016 | 36.89% |